Cefdinir Powder, For Suspension
Product Images NDC 63187-616

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 63187-616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Cedfinir Monohydrate (3509197f 5b82 408d 81d6 3a41b294c53a 01)

Chemical structure diagram of Cefdinir, showing its molecular arrangement with labeled atoms and bonds, including sulfur (S), nitrogen (N), and oxygen (O), as well as the molecule's hydrate form (H2O).*

FDA Label Image

63187-616-60 (3509197f 5b82 408d 81d6 3a41b294c53a 03)

Label for Cefdinir 250 mg/5 mL oral suspension, 100 mL bottle by Proficient Rx LP. The label states each 5 mL contains 250 mg cefdinir after reconstitution. Manufacturer is Teva Pharmaceuticals USA, with storage instructions between 20°-25°C. NDC 63187-616-00 and warnings to keep out of children’s reach are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.